i-Virtual, France’s leading company in camera-based monitoring of physiological parameters, has announced a €3 million funding round, welcoming Malakoff Humanis as an investor through a partnership between its CVC ‘MH Innov’ and Elaia.
The team is also delighted with the continued support of its historical investors: Elaia and UI Investissement. This new injection of capital will be mainly dedicated to i-Virtual’s commercial expansion in Europe and the continued development of its camera-based blood pressure measurement technology.
Thanks to this round of financing, i-Virtual intends to achieve European expansion integrating its cutting-edge technology into a growing number of telemedicine platforms to ensure better remote connections between healthcare professionals and patients. The company will also finalise its R&D work on camera-based blood pressure measurement, opening up new possibilities for remote medical monitoring and the prevention of cardiovascular disease. i-Virtual will continue to innovate and develop its roadmap for researching new biomarkers through the camera, paving the way for innovative medical applications.
“We are delighted to welcome Malakoff Humanis as a strategic industrial partner in this crucial phase of our growth. We have a long history of strong interest from the insurance sector, and this investment through the partnership between Malakoff Humanis and Elaia confirms i-Virtual’s strategic positioning,” said Gaël Constancin, i-Virtual’s CEO. “Their expertise and commitment to innovation align perfectly with i-Virtual’s vision. This additional funding will enable us to accelerate the development of our products and consolidate our leading position in the market.”
The Metz-based company, which has developed the first CE-certified as a Medical Device technology for measuring vital signs through a simple video selfie, is continuing its commercial expansion across Europe and aims to achieve profitability.
The cardio-respiratory and well-being parameters measured using its camera-based technology are useful in a wide range of applications, including telemedicine (teleconsultation, remote monitoring of chronic pathologies, mental health, etc.), health prevention and well-being. i-Virtual can already count clients from 5 European countries in the telemedicine sector, and is developing partnerships with prestigious players in the automotive and aerospace industries.
For this funding round, i-Virtual also succeeded in bringing together more than a hundred Business Angels by raising part of its funds via the TUDIGO crowdfunding platform.
In addition to the capital investment, i-Virtual can count on the support of the Grand Est region which, through Bpifrance, is once again showing its support by providing funding as part of the “Grand Est – France 2030 regionalised” scheme.
“This investment is in line with Malakoff Humanis’ desire to seek out more disruptive technology for the benefit of our customers on a daily basis, and thus to integrate I-Virtual’s solution into our offerings. Our investment also illustrates our objective of supporting the best start-ups in the healthcare deep tech sector in order to develop the impact of digital health across the country, particularly in areas where it is becoming difficult to obtain physical medical appointments. We are proud to be able to support I-Virtual, a French nugget in the health deep-tech space, to help it achieve this shared ambition”, commented Gauthier Lalande, Executive Director of MH Innov’.
At Elaia, Céline Passedouet, Investment Manager and Florian Denis, Investment Director, added: “As historical investors in i-Virtual, we are very pleased to participate in this new funding round aimed at increasing the company’s development ambitions. We are delighted to be working alongside the MH Innov’ team to continue supporting this exceptional and complementary team of deep tech entrepreneurs.”
“The entry of a major player in the insurance sector such as Malakoff Humanis as a shareholder marks a turning point in the history of i-Virtual, demonstrating the interest of its cutting-edge technology in the insurance pathway,” mentiones Pauline De Breteuil, Associate Director UI Investissement – Majycc Innovation Santé.
Founded in 2014, i-Virtual is revolutionising digital health with a camera-based remote patient monitoring solution. Using AI and computer vision technology for real-time accuracy, our solution improves prevention and health monitoring. Our aim is to democratise access to quality care and make healthcare more proactive rather than reactive. By leveraging AI, computer vision, signal processing and cloud technologies, we are transforming the healthcare sector, making remote monitoring a standard in health management.
Read the orginal article: https://www.eu-startups.com/2023/12/metz-based-i-virtual-snaps-e3-million-to-expand-in-europe-its-camera-based-blood-pressure-measurement-tech/
